• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氯氟的亲电加成反应在正电子发射断层扫描示踪剂中的应用。

Electrophilic addition of chlorine monofluoride for PET tracers.

机构信息

Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland.

出版信息

Mol Imaging Biol. 2013 Apr;15(2):131-5. doi: 10.1007/s11307-012-0584-9.

DOI:10.1007/s11307-012-0584-9
PMID:22869463
Abstract

PURPOSE

We have studied the utility of [(18)F]ClF electrophilic addition to the carbon-carbon double bond of analogues of a model positron emission tomography (PET) tracer, [(18)F]EF5. The consequence of simultaneous chlorine/fluorine addition on lipophilicity and biological activity of the molecule is evaluated.

PROCEDURES

Post-target produced [(18)F]F2 was reacted with Cl2 to produce [(18)F]ClF, which was used in electrophilic addition.

RESULTS

[(18)F]ClF was produced and used to label chlorinated analogues of [(18)F]EF5. The chlorinated analogues, [(18)F]EF4Cla and [(18)F]EF4Clb, were synthesized simultaneously. The in vivo uptake of the analogues compared well with [(18)F]EF5 uptake in tumor-bearing mice.

CONCLUSION

[(18)F]ClF is a suitable labeling reagent for electrophilic addition to double bonds of PET tracers. The results show that the modification of the pentafluoro group of [(18)F]EF5 by monofluorine-for-chlorine exchange affected the lipophilicity, but the hypoxia avidity of these molecules was not apparently altered.

摘要

目的

我们研究了 [(18)F]ClF 的亲电加成反应在模型正电子发射断层扫描 (PET) 示踪剂 [(18)F]EF5 类似物的碳-碳双键中的应用。评估了氯/氟同时加成对分子亲脂性和生物活性的影响。

过程

靶后产生的 [(18)F]F2 与 Cl2 反应生成 [(18)F]ClF,用于亲电加成。

结果

[(18)F]ClF 被合成并用于标记 [(18)F]EF5 的氯化类似物 [(18)F]EF4Cla 和 [(18)F]EF4Clb。这些类似物在荷瘤小鼠体内的摄取与 [(18)F]EF5 的摄取相当。

结论

[(18)F]ClF 是一种适合用于 PET 示踪剂双键的亲电加成反应的标记试剂。结果表明,[(18)F]EF5 的五氟基团被单氟-氯取代的修饰影响了亲脂性,但这些分子的缺氧亲和力并没有明显改变。

相似文献

1
Electrophilic addition of chlorine monofluoride for PET tracers.一氯氟的亲电加成反应在正电子发射断层扫描示踪剂中的应用。
Mol Imaging Biol. 2013 Apr;15(2):131-5. doi: 10.1007/s11307-012-0584-9.
2
Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5.缺氧示踪剂 [(18)F]EF5 的示踪剂亲电合成与药代动力学研究。
Mol Imaging Biol. 2012 Apr;14(2):205-12. doi: 10.1007/s11307-011-0484-4.
3
18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.18F-EF5:一种用于头颈癌缺氧成像的新型正电子发射断层显像剂
J Nucl Med. 2008 Dec;49(12):1944-51. doi: 10.2967/jnumed.108.053785. Epub 2008 Nov 7.
4
Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.(18)F-EF5 在癌症患者中的生物分布和剂量学研究,初步比较(18)F-EF5 摄取与 EF5 与人脑胶质母细胞瘤结合。
Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2048-59. doi: 10.1007/s00259-010-1517-y. Epub 2010 Jun 29.
5
[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure.[18F]-EF5,一种用于正电子发射断层扫描(PET)检测缺氧的标记物:前体的合成及一种新的氟化程序
Appl Radiat Isot. 2001 Jan;54(1):73-80. doi: 10.1016/s0969-8043(00)00102-0.
6
F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.基于 F-EF5 PET 的可成像缺氧预测接受高度适形放射治疗的肿瘤局部复发。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1183-1192. doi: 10.1016/j.ijrobp.2018.03.045. Epub 2018 Apr 18.
7
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.缺氧示踪剂 (18)F-EF5 在肿瘤患者中的辐射剂量学和生物分布。
Cancer Biother Radiopharm. 2012 Sep;27(7):412-9. doi: 10.1089/cbr.2011.1130. Epub 2012 Aug 16.
8
Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.在三种不同的人肿瘤异种移植模型中,缺氧正电子发射断层显像剂(18)F-EF5与免疫组化标志物EF5的比较
J Nucl Med. 2014 Jul;55(7):1192-7. doi: 10.2967/jnumed.114.137448. Epub 2014 May 22.
9
Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.使用2-硝基咪唑18F-EF5对大鼠肿瘤缺氧进行无创成像。
Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):259-66. doi: 10.1007/s00259-002-1037-5. Epub 2002 Nov 23.
10
18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.18F-EF5 PET 成像作为缺氧激活前药 SN30000 联合放射治疗在非小细胞肺癌异种移植模型中的早期反应生物标志物。
J Nucl Med. 2013 Aug;54(8):1339-46. doi: 10.2967/jnumed.112.116293. Epub 2013 Jun 5.

引用本文的文献

1
18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme.18F-谷胱甘肽缀合物作为一种正电子发射断层显像(PET)示踪剂,用于对过表达L-PGDS酶的肿瘤进行成像。
PLoS One. 2014 Aug 11;9(8):e104118. doi: 10.1371/journal.pone.0104118. eCollection 2014.

本文引用的文献

1
The unique role of halogen substituents in the design of modern agrochemicals.卤素取代基在现代农用化学品设计中的独特作用。
Pest Manag Sci. 2010 Jan;66(1):10-27. doi: 10.1002/ps.1829.
2
Molecular imaging of hypoxia with radiolabelled agents.用放射性标记剂对缺氧进行分子成像。
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1674-86. doi: 10.1007/s00259-009-1195-9. Epub 2009 Jun 30.
3
18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.18F-EF5:一种用于头颈癌缺氧成像的新型正电子发射断层显像剂
J Nucl Med. 2008 Dec;49(12):1944-51. doi: 10.2967/jnumed.108.053785. Epub 2008 Nov 7.
4
Imaging of tumor hypoxia to predict treatment sensitivity.肿瘤缺氧成像以预测治疗敏感性。
Curr Pharm Des. 2008;14(28):2932-42. doi: 10.2174/138161208786404380.
5
Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.缺氧与侵袭性肿瘤表型:对治疗和预后的影响。
Oncologist. 2008;13 Suppl 3:21-6. doi: 10.1634/theoncologist.13-S3-21.
6
Molecular imaging with PET.正电子发射断层显像(PET)分子成像
Chem Rev. 2008 May;108(5):1501-16. doi: 10.1021/cr0782426. Epub 2008 Apr 22.
7
Hypoxia--a key regulatory factor in tumour growth.缺氧——肿瘤生长中的关键调节因子。
Nat Rev Cancer. 2002 Jan;2(1):38-47. doi: 10.1038/nrc704.
8
Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.EF5 [2-(2-硝基-1-H-咪唑-1-基)-N-(2,2,3,3,3-五氟丙基)乙酰胺] 在人类患者中的药代动力学:对2-硝基咪唑类药物体内缺氧测量的意义。
Cancer Chemother Pharmacol. 2001 Sep;48(3):177-87. doi: 10.1007/s002800100324.
9
Pharmacokinetics of [18F]FETNIM: a potential marker for PET.[18F]FETNIM的药代动力学:一种正电子发射断层扫描(PET)的潜在标志物。
J Nucl Med. 2001 Sep;42(9):1397-404.
10
Fluorine-18-labeled fluorine gas for synthesis of tracer molecules.用于合成示踪分子的氟 - 18标记氟气。
Nucl Med Biol. 1997 Oct;24(7):677-83. doi: 10.1016/s0969-8051(97)00078-4.